Docking, Molecular Dynamics and MMPBSA Study of Selected FDA-Approved Drugs Against SARS-CoV-2 Proteases and Spike Proteins
Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), rapidly evolved into a global health emergency. Despite extensive research efforts, the lack of fully effective and specific antiviral therapies during the early stages of the pan...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
University of Mosul, College of Pharmacy
2026-03-01
|
| Col·lecció: | المجلة العراقية للصيدلة |
| Matèries: | |
| Accés en línia: | https://iphr.uomosul.edu.iq/article_190587_e108a8d20f41b9d4e19389355eaa7a51.pdf |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|